Gene: TMOD4
Official Full Name: tropomodulin 4provided by HGNC
Gene Summary: Predicted to enable tropomyosin binding activity. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Located in striated muscle thin filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27056 | TMOD4 Knockout cell line (HeLa) | Human | TMOD4 | 1:3~1:6 | Negative | Online Inquiry |
KO27057 | TMOD4 Knockout cell line (HCT 116) | Human | TMOD4 | 1:2~1:4 | Negative | Online Inquiry |
KO27058 | TMOD4 Knockout cell line (HEK293) | Human | TMOD4 | 1:3~1:6 | Negative | Online Inquiry |
TMOD4 Gene Knockout Cell Lines represent a cutting-edge advancement in cellular research, designed specifically to facilitate the study of the tropomodulin 4 (TMOD4) gene and its associated pathways. These cell lines have undergone targeted genetic modification to produce an effective knockout of the TMOD4 gene, thereby enabling researchers to explore the functional implications of TMOD4 in cellular processes such as actin cytoskeletal dynamics, muscle contraction, and cellular signaling mechanisms.
The key function of TMOD4 Gene Knockout Cell Lines lies in their ability to provide a controlled environment in which the effects of the absence of TMOD4 can be analyzed. By employing CRISPR-Cas9 gene-editing technology, these cell lines exhibit precisely defined characteristics that allow for the exploration of cellular responses to various stimuli, including changes in mechanical stress, growth factors, and drug treatments. The resulting data can lead to a deeper understanding of how alterations in TMOD4 influence cellular architecture and function.
The scientific importance of TMOD4 Gene Knockout Cell Lines extends to multiple research fields, including developmental biology, cardiovascular research, and cancer studies. By elucidating the role of TMOD4, researchers can uncover vital insights into muscle-related diseases, heart conditions, and potential therapeutic targets in oncology. Their application in clinical research settings can significantly enhance the understanding of disease mechanisms and contribute to the development of innovative treatments.
Compared to alternative models, such as transient knockdown systems, TMOD4 Gene Knockout Cell Lines provide a stable and reproducible platform that facilitates longitudinal studies of TMOD4 loss-of-function effects. This stability minimizes variability, allowing for clearer interpretation of experimental results and contributing to robust data generation.
For researchers and clinicians alike, TMOD4 Gene Knockout Cell Lines present an invaluable tool in the quest for discovery and innovation. The precise genetic editing capabilities, along with the insights into TMOD4 functionality, empower users to derive meaningful conclusions that can influence both basic research and clinical applications.
As a leader in the production of genetically modified cell lines, our company is dedicated to providing high-quality biological products that meet the evolving needs of the scientific community. Our expertise ensures that each cell line is developed with rigorous quality control and comprehensive documentation, delivering reliable solutions to advance your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.